Nuzenio

Impact Beam Therapeutics

Impact Beam Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 4 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Analysts Have Lowered Expectations For Beam Therapeutics Inc. (NASDAQ:BEAM) After Its Latest Results - simplywall.stsimplywall.st · Fri, 07 Aug 2026 15:45:39 GMTHow Beam’s Wider Q2 Loss and Trial Progress Will Impact Beam Therapeutics (BEAM) Investors - simplywall.stsimplywall.st · Thu, 06 Aug 2026 14:39:58 GMTRBC Capital Keeps Their Hold Rating on Beam Therapeutics (BEAM) - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 12:03:00 GMTBeam Therapeutics reports Q2 EPS ($1.18), consensus ($1.13) - TipRanksTipRanks · Tue, 04 Aug 2026 13:01:05 GMT

Timeline

Fri, 07 Aug 2026 15:45:39 GMTAnalysts Have Lowered Expectations For Beam Therapeutics Inc. (NASDAQ:BEAM) After Its Latest Results - simplywall.st
Thu, 06 Aug 2026 14:39:58 GMTHow Beam’s Wider Q2 Loss and Trial Progress Will Impact Beam Therapeutics (BEAM) Investors - simplywall.st
Thu, 06 Aug 2026 12:03:00 GMTRBC Capital Keeps Their Hold Rating on Beam Therapeutics (BEAM) - The Globe and Mail
Tue, 04 Aug 2026 13:01:05 GMTBeam Therapeutics reports Q2 EPS ($1.18), consensus ($1.13) - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Impact Beam Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.